Free Trial

Envista (NVST) Competitors

Envista logo
$21.57 +0.68 (+3.26%)
Closing price 03:59 PM Eastern
Extended Trading
$21.56 -0.01 (-0.05%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NVST vs. BRBR, SNN, SOLV, PEN, STVN, IRTC, GKOS, BLCO, TMDX, and SLNO

Should you be buying Envista stock or one of its competitors? The main competitors of Envista include BellRing Brands (BRBR), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), and Soleno Therapeutics (SLNO).

Envista vs. Its Competitors

BellRing Brands (NYSE:BRBR) and Envista (NYSE:NVST) are related mid-cap companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

BellRing Brands has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, Envista has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.

BellRing Brands has a net margin of 10.26% compared to Envista's net margin of 2.11%. Envista's return on equity of 4.84% beat BellRing Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
BellRing Brands10.26% -123.43% 30.88%
Envista 2.11%4.84%2.68%

BellRing Brands currently has a consensus price target of $67.86, indicating a potential upside of 71.57%. Envista has a consensus price target of $20.92, indicating a potential downside of 3.00%. Given BellRing Brands' stronger consensus rating and higher probable upside, equities research analysts clearly believe BellRing Brands is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BellRing Brands
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.86
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33

BellRing Brands has higher earnings, but lower revenue than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BellRing Brands$2.00B2.52$246.50M$1.7522.60
Envista$2.51B1.43-$1.12B$0.3267.41

95.0% of BellRing Brands shares are owned by institutional investors. 1.1% of BellRing Brands shares are owned by insiders. Comparatively, 0.7% of Envista shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, BellRing Brands had 43 more articles in the media than Envista. MarketBeat recorded 47 mentions for BellRing Brands and 4 mentions for Envista. Envista's average media sentiment score of 0.74 beat BellRing Brands' score of 0.49 indicating that Envista is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BellRing Brands
17 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Neutral
Envista
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

BellRing Brands beats Envista on 11 of the 17 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$3.47B$10.54B$5.55B$20.89B
Dividend YieldN/A1.97%4.62%3.60%
P/E Ratio67.4120.0630.1528.44
Price / Sales1.4324.84460.8460.00
Price / Cash12.5724.0537.7523.46
Price / Book1.143.138.475.45
Net Income-$1.12B$209.94M$3.26B$994.60M
7 Day Performance9.56%8.82%3.56%3.03%
1 Month Performance6.84%9.93%5.97%1.98%
1 Year Performance26.96%-6.89%42.70%16.39%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
3.8228 of 5 stars
$21.57
+3.3%
$20.92
-3.0%
+28.7%$3.47B$2.51B67.4112,300
BRBR
BellRing Brands
4.7009 of 5 stars
$53.48
-1.2%
$76.06
+42.2%
-28.5%$6.87B$2.00B25.05380
SNN
Smith & Nephew SNATS
2.2975 of 5 stars
$30.79
-0.1%
$28.00
-9.1%
+23.0%$13.49B$5.81B14.2617,349Dividend Cut
SOLV
Solventum
2.2292 of 5 stars
$73.24
+2.1%
$84.38
+15.2%
+24.8%$12.67B$8.31B33.9122,000News Coverage
Earnings Report
PEN
Penumbra
4.7648 of 5 stars
$240.71
-0.9%
$300.47
+24.8%
+47.8%$9.39B$1.19B64.024,500News Coverage
Insider Trade
STVN
Stevanato Group
N/A€25.58
+1.8%
N/A+9.2%€7.75B€1.19B50.165,521Positive News
IRTC
iRhythm Technologies
1.9816 of 5 stars
$164.98
+0.0%
$157.30
-4.7%
+151.2%$5.30B$591.84M-56.312,000News Coverage
Insider Trade
GKOS
Glaukos
4.1214 of 5 stars
$87.52
+1.6%
$127.42
+45.6%
-26.5%$5.00B$383.48M-53.04780Positive News
BLCO
Bausch + Lomb
1.6579 of 5 stars
$13.76
+1.9%
$15.56
+13.0%
-11.4%$4.78B$4.79B32.1413,500
TMDX
TransMedics Group
2.493 of 5 stars
$128.50
+6.6%
$123.00
-4.3%
-19.6%$4.38B$531.29M66.58210
SLNO
Soleno Therapeutics
4.628 of 5 stars
$84.12
-2.2%
$108.70
+29.2%
+78.0%$4.24BN/A-18.2130Earnings Report
Analyst Revision

Related Companies and Tools


This page (NYSE:NVST) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners